ABSTRACT-Agmatine was about as potent as aminoguanidine to inhibit the activity of the inducible form of nitric oxide synthase (iNOS) in isolated rat aorta. Like aminoguanidine, agmatine was devoid of significant activity on the constitutive form of NOS. Agmatine inhibited the conversion of [3H]L-arginine in [3H]L-citrulline in partially purified iNOS from macrophages (IC50=262±39.9 pM). Thus, our data suggest that agmatine may act as endogenous inhibitor of iNOS.
L-Arginine is a nutritionally semiessential amino acid involved in a variety of physiological processes (1) . Arginine plays a role in protein and creatine biosynthesis and, as an intermediate in the urea cycle, is converted to ornithine by arginase. However, other enzymes that catalyze the conversion of arginine have been identified. In this respect, nitric oxide synthase (NOS) produces the potent vasodilator nitric oxide (NO) (2, 3) , and arginine decarboxylase converts arginine to agmatine (4) . This latter enzyme, orginally observed in bacteria, has been recently found in mammalian brain (5) . In addition, agmatine was identified as an endogenous clonidine-displacing substance (5) . Thus, it was hypothesized that arginine may have an antihypertensive effect through NO and agmatine formation by NOS and arginine decarboxylase, respectively (6). However, Pinthong et al. (7) showed that despite recognition at a2-adrenoceptor binding sites, agmatine failed to produce functional a2-adrenoceptor activity not only in the isolated guinea pig ileum but also in other functional models of a2-adrenoceptors. In this respect, agmatine failed to mimic the effect of clonidine in isolated rat vas deferens or isolated porcine palmar lateral vein. In addition, in rat cerebral cortex, agmatine produced a concentrationdependent inhibition of 3H-clonidine, but failed, unlike UK-14304, to inhibit forskolin-stimulated cyclic AMP. Thus collectively, the results indicate that agmatine may not posses sufficient a2-adrenoceptor agonist properties to influence cardiovascular function as recently observed (8) . Although a possible role of agmatine as a substrate for NOS has been ruled out (9) , other guanidines such as aminoguanidine may act against NO formation (10).
Thus, the aim of this study was to test the possible interaction of agmatine with NO synthesis. Thoracic aortae were excised from male Sprague Dawley rats (270-360g;
Charles River, Paris, France). Rings, 2-mm-wide, were suspended (2 g tension) in organ baths containing 20 ml of Krebs-Henseleit solution (for composition see below) at 371C and gassed with 95% 02 /5% CO2. After a 1-hr rest period, contractile responses were measured using force-displacement transducers connected to a data collection system (IOS; Dei Leirre, Mitry Mory, France). Physiological solution was composed of: 118 mM NaCl, 4.7 mM KC1, 2.5 mM CaC12, 1.2 mM KH2PO4, 1.2 mM MgSO4, 25 mM NaHCO3 and 11 mM glucose.
In a first series of experiments, rings possessing a functional endothelium were precontracted with phenylephrine (PE, 1 yM; 90% -95% of maximal tone) and then maximally relaxed with carbachol (10 pM). This contraction-relaxation protocol was repeated in the presence or absence of the tested drugs after a 45-min washing period. In a second set of experiments, endothelium-free rings were incubated for 5 hr in minimal essential medium with or without endotoxin (10 pg/ml) prior to study. Under these conditions, a loss of contraction tonicity to PE (10 pM) was observed. This phenomenon has previously been attributed to the induction of NOS (11) (12) (13) (14) . The drugs were added after 60 min of PE-induced contraction when the contractile impairment was maximal.
The murine macrophage cell line J774A1 was cultured in DMEM with 10% fetal calf serum. Cells were exposed to lipopolysaccharide (LPS) (1 pg/ml) and interferon-7 (50 U/ml) for 24 hr to induce iNOS (inducible NOS). 1 pM) . Lack of effect of aminoguanidine (Ami, 300 pM) and agmatine (Agma, 300 pM) and inhibition by NG-nitro-L-arginine (NLA, 100 pM) of the relaxation induced by Carb. Two lower panels: Loss of tonicity of PE (10 ,UM) induced contraction in endothelium free ring of rat aorta incubated 5 hr in the presence of endotoxin (10 ug/ml) and the effect of aminoguanidine and agmatine added to the bath 60 min after PE. The reversing effect of L-arginine (Larg, 1 mM) was also observed. The same results were observed in the preparations from at least four different animals. IC50 values were calculated by computer analysis.
As shown in Fig. 1 , carbachol (10 pM) completely relaxed rings of rat aorta with intact endothelium precontracted with PE (1 uM). Neither aminoguanidine (300 pM), a specific antagonist of iNOS (16), nor agmatine (300 pM) affected this relaxation, whereas N°-nitro-L-arginine (100 pM), added after total relaxation by carbachol, restored the contraction to PE.
A 5-hr incubation of endothelium-free rings in the presence of endotoxin (10 pg/ml) resulted in a loss of tonicity of the contractile response of PE (10 pM). We have previously demonstrated that the impairment of vascular reactivity is associated with an overproduction of NO from iNOS and reflects its activation (11) (12) (13) (14) . Both aminoguanidine and agmatine were able to restore in a dose-dependent manner the contractile response to PE ( Figs. 1 and 2) . A threefold excess of L-arginine rapidly and totally reversed the effect of agmatine (Fig.  1) . The 24-hr incubation of macrophages with LPS and interferon-r resulted in the induction of iNOS (9) manner. The present study shows the effects of agmatine on the constitutive and the inducible forms of vascular NOS activity. Both aminoguanidine and agmatine, unlike NGnitro-Larginine, are unable to counteract the relaxing effect of carbachol on endothelium intact rings of rat aorta precontracted with PE, indicating a lack of interaction of the two compounds on the constitutive form of NOS. In contrast, in rat aorta rings incubated in the presence of endotoxin, the loss of tonicity of the contractile response to PE that reflects activation of iNOS (11) (12) (13) (14) is counteracted by aminoguanidine and agmatine. In this respect, agmatine is about as potent and selective as aminoguanidine to inhibit the activity of iNOS. The effect of agmatine is likely due to a direct action on the enzyme since agmatine inhibits the conversion of [3H]L-arginine in [3H]L-citrulline by iNOS partially purified from macrophages. However, in this model, agmatine was about 20-fold less potent than aminoguanidine.
In conclusion, our study indicates that agmatine may impair NO synthesis from arginine by inhibition of iNOS. This effect is exhibited much strongly at the vascular level; thus, since endothelial cells synthesize and store agmatine (17) , the role of agmatine as an endogenous inhibitor of vascular iNOS deserves further investigation.
